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Appraisal Critically Appraised Papers
Lateral wedge insoles worn for 12 months provided no 
symptomatic or structural beneﬁt for people with  
medial knee osteoarthritis
Synopsis
Summary of: Bennell KL et al (2011) Lateral wedge insoles 
for medial knee osteoarthritis: 12 month randomised 
controlled trial. BMJ 342: d2912 doi:10.1136/bmj.d2912 
[Prepared by Margreth Grotle and Kåre Birger Hagen, CAP 
Editors.]
Question: Do lateral wedge insoles or ﬂat control insoles 
improve symptoms and slow structural disease progression 
in medial knee osteoarthrits? Design: A double blind 
randomised, controlled trial with stratiﬁcation by disease 
severity (Kellgren and Lawrence Grades 2 and 3) and sex. 
Group allocation was carried out in permuted blocks of 6 
to 12 using an independent researcher. Setting: Community 
setting in Melbourne, Australia. Participants: Men and 
women of 50 years or more with average knee pain on 
walking of more than 3 on an 11-point numerical rating scale 
(0 = no pain, 10 = worst pain possible) at telephone screening, 
pain located over the medial knee compartment, evidence 
of osteophytes in the medial compartment or medial joint 
space narrowing on an X-ray ﬁlm, and radiological knee 
alignment of 185 deg or less indicating neutral to varus 
(bow leg) knee alignment. Key exclusion criteria included 
questionable or advanced radiographic knee osteoarthritis 
(Kellgren and Lawrence Grades 1 and 4), predominant 
patellofemoral joint symptoms on clinical examination, knee 
surgery or intra-articular corticosteroid injection within six 
months, and regular use of a gait aid. Randomisation of 200 
participants allocated 103 to wear wedged insoles and 97 to 
wear ﬂat control insoles. Interventions: Participants wore 
the insoles bilaterally in their own shoes every day. They 
were provided with two pairs of insoles, which were replaced 
every four months. The lateral wedge (5 degrees) insoles 
were made of high density ethyl vinyl acetate (similar to 
the midsole in a running shoe) and were wedged along the 
lateral border of the foot. The control insoles were made of 
easily compressible low density ethyl vinyl acetate but with 
no wedging. Outcome measures: Primary symptomatic 
outcome was change in overall average knee pain (past 
week). Primary structural outcome was change in volume 
of medial tibial cartilage from magnetic resonance imaging 
scans. Secondary symptomatic measures included changes 
of pain, function, stiffness, and health-related quality-of-
life. Secondary structural outcome included progression of 
medial cartilage defects and bone marrow lesions. Results: 
179 (89 lateral wedge insoles, 90 control insoles) out of 200 
participants completed the trial. After 12 months between-
group differences did not differ signiﬁcantly for the primary 
outcomes of change in overall pain (−0.3 points, 95% CI 
−1.0 to 0.3) and change in medial tibial cartilage volume 
(−0.4 mm3, 95% CI −15.4 to 14.6), and conﬁdence intervals 
did not include minimal clinically important differences. 
None of the changes in secondary outcomes showed 
differences between groups. Conclusion: Lateral wedge 
insoles worn for 12 months provided no symptomatic or 
structural beneﬁts compared with ﬂat control insoles.
Commentary
Weak recommendations based on low level evidence 
preceded the publication of a previous randomised 
controlled trial comparing the ideal condition of custom 
lateral wedged insoles to neutral insoles in the same walking 
shoes that found no difference at one year (Barrios et al 
2009). The American Academy of Orthopaedic Surgeons 
Guideline on the Treatment of Knee Osteoarthritis 
guideline, published in 2009, consequently stated ‘We 
suggest lateral heel wedges not be prescribed for patients 
with symptomatic medial compartmental OA of the knee. 
Level of Evidence: II, Grade of Recommendation: B’ 
(Richmond et al 2010). This well-designed and executed 
study by Professor Bennell and colleagues demonstrates that 
in the most common prescription of these orthoses (off-the-
shelf orthoses in the patient’s own shoes), there is no beneﬁt 
in symptoms or progression of disease. ‘First, do no harm’ 
is the maxim from which the principal precepts of medical 
ethics, nonmaleﬁcence, is derived. Nearly half of the 
participants complained that the lateral wedge insole caused 
discomfort; in 10% of these individuals the discomfort was 
severe. While 30% of participants in the neutral orthoses 
group had some discomfort, only 1% was rated as severe. 
While prescription of insoles is inexpensive and simple, it 
is now clear that lateral insoles provide no therapeutic or 
disease modifying beneﬁt and cause discomfort in a large 
percentage of patients. This study should sound the death 
knell for the use of lateral wedged insoles for the treatment 
of medial compartment knee osteoarthritis.
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